Blueprint Medicines Corp (BPMC) poses a Brand-New Opportunity for Investors with beta value of 0.74
Witnessing the stock’s movement on the chart, on Wednesday, Blueprint Medicines Corp (NASDAQ: BPMC) set off with pace as it heaved 0.61% to $89.92, before